Pharma Reviews: Pharma cos to drive growth, diversify products via M&As: Moody's

Indian generic pharma majors are expected to explore these M&As amid slowing growth in their global revenue, according to the firm's latest report on ...
Read more: Pharma cos to drive growth, diversify products via M&As: Moody's